Abteilungen

Abteilung Hämatologie und Onkologie

Leitung

Direktor der Abteilung
Prof. Dr. Lorenz Trümper

Sekretariat

Telefon: +49 (0) 551 39-85 35
Fax: +49 (0) 551 39-85 87
E-Mail: lorenz.truemper@med.uni-goettingen.de

Patientenanmeldung

Telefon: +49 (0) 551 39-105 22, 39-105 21

Anschrift

Robert-Koch-Str. 40
37075 Göttingen

Briefpostadresse

37099 Göttingen

Homepage

www.onkologie-haematologie.med.uni-goettingen.de
Universitäts-Krebszentrum G-CCC

Downloads

Forschungsbericht 2006-2008 2003-2005

Publikationen 2010 2009 2008 2007 2006 2005

Qualitätsbericht 2010 2008 2006

• Pukrop T, Dehghani F, Chuang HN, Lohaus R, Bayanga K, Heermann S, Regen T, van Rossum D, Klemm F, Schulz M, Siam L, Hoffmann A, Trümper L, Stadelmann Chr, Bechmann I, Hanisch UK, Binder C (2010):
  Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. GLIA, 58: 1477-89.
  
• Jannasch K, Dullin C, Heinlein C, Krepulat F, Wegwitz F, Deppert W, Alves F (2009):
  Detection of different tumor growth kinetics in single transgenic mice with oncogene induced mammary carcinomas by flat-panel Volume Computed Tomography (fpVCT). INT J CANCER, 1: 62-70.
  
• Schoof N, von Bonin F, Zeynalova S, Ziepert M, Jung W, Loeffler M, Pfreundschuh M, Trümper L, Kube D (2009):
  Favorable impact of the Interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients: A large prospective clinical trial study. ANN ONCOL, 20(9): 1548-54.
  
• Chapuy B, Koch R, Radunski U, Corsham S, Cheong N, Inagaki N, Ban N, Wenzel D, Reinhardt D, Zapf A, Schweyer S, Kosari F, Klapper W, Truemper L, Wulf GG (2008):
  Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration. LEUKEMIA, 22(8): 1576-86.
  
• Trümper L, Zwick C, Ziepert M, Hohloch K, Schmits R, Mohren M, Liersch R, Bentz M, Graeven U, Wruck U, Hoffmann M, Metzner B, Hasenclever D, Loeffler M, Pfreundschuh M (2008):
  German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL): Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens. ANN ONCOL, 19(3): 538-44.

Suchworte: Blut, CA, Knochenmarktransplantation, Knochenmark, Krebs, Leukämie, Lymphom, Targeted, Transplantation, Tumor